Kate Haviland Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kate Haviland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kate Haviland. Kate Haviland is Chief Business Officer in Blueprint Medicines Corp ($BPMC) and Chief Operating Officer in Blueprint Medicines Corp ($BPMC) and Director in Fulcrum Therapeutics, Inc. ($FULC).
Latest Insider Trading Transactions of Kate Haviland
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 1,000 | 36,050 | 3,591 | |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 104.65 | 322 | 33,697 | 53,948 | 54.3 K to 53.9 K (-0.59 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 105.44 | 426 | 44,917 | 54,270 | 54.7 K to 54.3 K (-0.78 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 106.62 | 108 | 11,515 | 54,696 | 54.8 K to 54.7 K (-0.20 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 107.42 | 138 | 14,824 | 54,804 | 54.9 K to 54.8 K (-0.25 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 108.16 | 6 | 649 | 54,942 | 54.9 K to 54.9 K (-0.01 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 1,000 | 36,050 | 54,948 | 53.9 K to 54.9 K (+1.85 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 1,000 | 36,050 | 3,591 | |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 104.65 | 322 | 33,697 | 53,948 | 54.3 K to 53.9 K (-0.59 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 105.44 | 426 | 44,917 | 54,270 | 54.7 K to 54.3 K (-0.78 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 106.62 | 108 | 11,515 | 54,696 | 54.8 K to 54.7 K (-0.20 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 107.42 | 138 | 14,824 | 54,804 | 54.9 K to 54.8 K (-0.25 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 108.16 | 6 | 649 | 54,942 | 54.9 K to 54.9 K (-0.01 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 1,000 | 36,050 | 54,948 | 53.9 K to 54.9 K (+1.85 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 86.61 | 1,828 | 158,323 | 53,948 | 55.8 K to 53.9 K (-3.28 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 89.09 | 124 | 11,047 | 55,776 | 55.9 K to 55.8 K (-0.22 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 409 | 14,744 | 4,591 | |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 100.27 | 409 | 41,010 | 42,838 | 43.2 K to 42.8 K (-0.95 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 409 | 14,744 | 43,247 | 42.8 K to 43.2 K (+0.95 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 13,334 | 480,691 | 5,000 | |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 100.55 | 7,200 | 723,960 | 42,838 | 50 K to 42.8 K (-14.39 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 101.56 | 3,125 | 317,375 | 50,038 | 53.2 K to 50 K (-5.88 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 102.53 | 3,009 | 308,513 | 53,163 | 56.2 K to 53.2 K (-5.36 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 13,334 | 480,691 | 56,172 | 42.8 K to 56.2 K (+31.13 %) |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 3,143 | 51,168 | 2 | |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 85.49 | 3,143 | 268,695 | 42,838 | 46 K to 42.8 K (-6.84 %) |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 3,143 | 51,168 | 45,981 | 42.8 K to 46 K (+7.34 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 4,644 | 75,604 | 3,145 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | A | 54.13 | 28,500 | 1,542,705 | 28,500 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 4,644 | 75,604 | 43,509 | 38.9 K to 43.5 K (+11.95 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Grant | A | 0.00 | 14,250 | 0 | 38,865 | 24.6 K to 38.9 K (+57.89 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 7,763 | 126,382 | 7,789 | |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 7,763 | 126,382 | 7,789 | |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 85.16 | 7,763 | 661,097 | 15,865 | 23.6 K to 15.9 K (-32.86 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 85.16 | 7,763 | 661,097 | 15,865 | 23.6 K to 15.9 K (-32.86 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 7,763 | 126,382 | 23,628 | 15.9 K to 23.6 K (+48.93 %) |
| Jan 14 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 7,763 | 126,382 | 23,628 | 15.9 K to 23.6 K (+48.93 %) |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 95 | 1,547 | 15,552 | |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 85.00 | 95 | 8,075 | 15,865 | 16 K to 15.9 K (-0.60 %) |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 95 | 1,547 | 15,960 | 15.9 K to 16 K (+0.60 %) |
| Jul 18 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 11,562 | 188,229 | 15,647 | |
| Jul 18 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 95.03 | 349 | 33,165 | 15,865 | 16.2 K to 15.9 K (-2.15 %) |
| Jul 18 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 95.60 | 1,222 | 116,823 | 16,214 | 17.4 K to 16.2 K (-7.01 %) |
| Jul 18 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 11,562 | 188,229 | 17,436 | 5.9 K to 17.4 K (+196.83 %) |
| Jul 18 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 11,562 | 188,229 | 15,647 | |
| Jul 18 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 95.03 | 349 | 33,165 | 15,865 | 16.2 K to 15.9 K (-2.15 %) |
| Jul 18 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 95.60 | 1,222 | 116,823 | 16,214 | 17.4 K to 16.2 K (-7.01 %) |
| Jul 18 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 11,562 | 188,229 | 17,436 | 5.9 K to 17.4 K (+196.83 %) |
| Jul 18 2019 | FULC | Fulcrum Therapeuti ... | Haviland Kate | Director | Option Exercise | A | 16.00 | 9,285 | 148,560 | 9,285 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 5,666 | 204,259 | 18,334 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 6,286 | 102,336 | 27,209 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 94.44 | 2,370 | 223,823 | 5,874 | 8.2 K to 5.9 K (-28.75 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 95.53 | 2,549 | 243,506 | 8,244 | 10.8 K to 8.2 K (-23.62 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 96.35 | 2,977 | 286,834 | 10,793 | 13.8 K to 10.8 K (-21.62 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 97.39 | 2,123 | 206,759 | 13,770 | 15.9 K to 13.8 K (-13.36 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 98.63 | 1,000 | 98,630 | 15,893 | 16.9 K to 15.9 K (-5.92 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 100.02 | 933 | 93,319 | 16,893 | 17.8 K to 16.9 K (-5.23 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 5,666 | 204,259 | 17,826 | 12.2 K to 17.8 K (+46.60 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 6,286 | 102,336 | 12,160 | 5.9 K to 12.2 K (+107.01 %) |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 7,500 | 270,375 | 24,000 | |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 16.28 | 14,144 | 230,264 | 33,495 | |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | A | 0.00 | 8,750 | 0 | 8,750 | |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | A | 86.60 | 32,500 | 2,814,500 | 32,500 | |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 85.05 | 21,644 | 1,840,822 | 5,874 | 27.5 K to 5.9 K (-78.65 %) |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 7,500 | 270,375 | 27,518 | 20 K to 27.5 K (+37.47 %) |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 16.28 | 14,144 | 230,264 | 20,018 | 5.9 K to 20 K (+240.79 %) |
| Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 36.05 | 2,500 | 90,125 | 118,139 | |
| Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 1,571 | 25,576 | 120,639 | |
| Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 99.20 | 571 | 56,643 | 5,874 | 6.4 K to 5.9 K (-8.86 %) |
| Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 100.02 | 1,200 | 120,024 | 6,445 | 7.6 K to 6.4 K (-15.70 %) |
| Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 101.32 | 1,800 | 182,376 | 7,645 | 9.4 K to 7.6 K (-19.06 %) |
| Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 102.19 | 500 | 51,095 | 9,445 | 9.9 K to 9.4 K (-5.03 %) |
| Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 36.05 | 2,500 | 90,125 | 9,945 | 7.4 K to 9.9 K (+33.58 %) |
| Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 1,571 | 25,576 | 7,445 | 5.9 K to 7.4 K (+26.74 %) |
| Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 36.05 | 3,200 | 115,360 | 125,010 | |
| Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 87.70 | 1,765 | 154,791 | 5,874 | 7.6 K to 5.9 K (-23.11 %) |
| Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 88.32 | 1,035 | 91,411 | 7,639 | 8.7 K to 7.6 K (-11.93 %) |
| Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 89.47 | 200 | 17,894 | 8,674 | 8.9 K to 8.7 K (-2.25 %) |
| Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 90.70 | 200 | 18,140 | 8,874 | 9.1 K to 8.9 K (-2.20 %) |
| Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 36.05 | 3,200 | 115,360 | 9,074 | 5.9 K to 9.1 K (+54.48 %) |
| Feb 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | A | 81.44 | 39,000 | 3,176,160 | 128,210 | |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 5,874 | 95,629 | 95,985 | |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 5,874 | 95,629 | 5,874 | 0 to 5.9 K |
| Oct 10 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 5,449 | 88,710 | 101,859 | |
| Oct 10 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 65.45 | 1,261 | 82,532 | 0 | 1.3 K to 0 (-100.00 %) |
| Oct 10 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 66.58 | 3,303 | 219,914 | 1,261 | 4.6 K to 1.3 K (-72.37 %) |
| Oct 10 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 67.33 | 885 | 59,587 | 4,564 | 5.4 K to 4.6 K (-16.24 %) |
| Oct 10 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 5,449 | 88,710 | 5,449 | 0 to 5.4 K |
| Sep 20 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 6,356 | 103,476 | 107,308 | |
| Sep 20 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 60.03 | 6,356 | 381,551 | 0 | 6.4 K to 0 (-100.00 %) |
| Sep 20 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 6,356 | 103,476 | 6,356 | 0 to 6.4 K |
| Jul 07 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 7,265 | 118,274 | 113,664 | |
| Jul 07 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 51.54 | 852 | 43,912 | 0 | 852 to 0 (-100.00 %) |
| Jul 07 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 52.63 | 700 | 36,841 | 852 | 1.6 K to 852 (-45.10 %) |
| Jul 07 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 53.58 | 700 | 37,506 | 1,552 | 2.3 K to 1.6 K (-31.08 %) |
| Jul 07 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 54.75 | 700 | 38,325 | 2,252 | 3 K to 2.3 K (-23.71 %) |
| Jul 07 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 55.76 | 4,313 | 240,493 | 2,952 | 7.3 K to 3 K (-59.37 %) |
| Jul 07 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 7,265 | 118,274 | 7,265 | 0 to 7.3 K |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 6,357 | 103,492 | 120,929 | |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 50.00 | 6,357 | 317,850 | 0 | 6.4 K to 0 (-100.00 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 6,357 | 103,492 | 6,357 | 0 to 6.4 K |
| Mar 16 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 12,714 | 206,984 | 87,286 | |
| Mar 16 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 40.01 | 12,714 | 508,687 | 0 | 12.7 K to 0 (-100.00 %) |
| Mar 16 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 12,714 | 206,984 | 12,714 | 0 to 12.7 K |
| Feb 21 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | A | 36.05 | 40,000 | 1,442,000 | 140,000 | |
| Feb 02 2016 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | A | 16.28 | 100,000 | 1,628,000 | 100,000 |
Page: 1